The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
By 2010 Soliris was considered to be the most expensive drug in the world. It costs Â£340,200 (approximately â¬430,000) per year for ongoing treatment in the UK and $500,000 a year in Canada. and US$409,500 a year in the United States (2010).